Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting Condition
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to asses the bioequivalence study of Fluoxetine Hydrochloride
Delayed-Release Capsules, 90 mg and Prozac ® weekly under fasting conditions.